Global Scopolamine Market Analysis with Players, Regions, Types, Applications 2018-2025
Latest Report Available at Decision Market Reports on Global Scopolamine Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
(EMAILWIRE.COM, November 21, 2018 ) Global Scopolamine Market Insights, Forecast to 2025: This report studies the global market size of Scopolamine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Scopolamine in these regions.
This research report categorizes the global Scopolamine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
Request a Free PDF Sample Report @ http://decisionmarketreports.com/request-sample?productID=858430
Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
The global production of scopolamine about 2450 Kg in 2015, the production region is mainly concentrated in Australia witch product 43.63% of global scopolamine. The top three companies are Alkaloids of Australia, Centroflora-cms and Fine Chemicals Corporation, they occupies about 62.37% market shares.
Although the production region is very concentration, the consumption region is very dispersion, in 2015, the largest consumption North America is about 30.68%, the Europe consumes about 26.65% market share, China occupies about 9.88% market share, Japan occupies about 10.78% market share.
In 2017, the global Scopolamine market size was 16 million US$ and is forecast to 20 million US in 2025, growing at a CAGR of 3.0% from 2018. The objectives of this study are to define, segment, and project the size of the Scopolamine market based on company, product type, application and key regions.
Browse Complete Report with Table of Content @ http://decisionmarketreports.com/market-reports/858430/global-scopolamine-market
The various contributors involved in the value chain of Scopolamine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Scopolamine include
Alkaloids of Australia
Centroflora-cms
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
Market Size Split by Type
Scopolamine Butylbromide
Scopolamine Hydrobromide
Scopolamine Base
Market Size Split by Application
Oral
Injection
Patches
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Scopolamine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Scopolamine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Scopolamine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Scopolamine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Scopolamine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Scopolamine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Scopolamine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Scopolamine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Scopolamine Market Size Growth Rate by Type
1.4.2 Scopolamine Butylbromide
1.4.3 Scopolamine Hydrobromide
1.4.4 Scopolamine Base
1.5 Market by Application
1.5.1 Global Scopolamine Market Size Growth Rate by Application
1.5.2 Oral
1.5.3 Injection
1.5.4 Patches
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Scopolamine Market Size
2.1.1 Global Scopolamine Revenue 2016-2025
2.1.2 Global Scopolamine Sales 2016-2025
2.2 Scopolamine Growth Rate by Regions
2.2.1 Global Scopolamine Sales by Regions
2.2.2 Global Scopolamine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Scopolamine Sales by Manufacturers
3.1.1 Scopolamine Sales by Manufacturers
3.1.2 Scopolamine Sales Market Share by Manufacturers
3.1.3 Global Scopolamine Market Concentration Ratio (CR5 and HHI)
3.2 Scopolamine Revenue by Manufacturers
3.2.1 Scopolamine Revenue by Manufacturers (2016-2018)
3.2.2 Scopolamine Revenue Share by Manufacturers (2016-2018)
3.3 Scopolamine Price by Manufacturers
3.4 Scopolamine Manufacturing Base Distribution, Product Types
3.4.1 Scopolamine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Scopolamine Product Category
3.4.3 Date of International Manufacturers Enter into Scopolamine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Scopolamine Sales by Type
4.2 Global Scopolamine Revenue by Type
4.3 Scopolamine Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Scopolamine Breakdown Data by Application
6 North America
6.1 North America Scopolamine by Countries
6.1.1 North America Scopolamine Sales by Countries
6.1.2 North America Scopolamine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Scopolamine by Type
6.3 North America Scopolamine by Application
6.4 North America Scopolamine by Company
7 Europe
7.1 Europe Scopolamine by Countries
7.1.1 Europe Scopolamine Sales by Countries
7.1.2 Europe Scopolamine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Scopolamine by Type
7.3 Europe Scopolamine by Application
7.4 Europe Scopolamine by Company
8 Asia Pacific
8.1 Asia Pacific Scopolamine by Countries
8.1.1 Asia Pacific Scopolamine Sales by Countries
8.1.2 Asia Pacific Scopolamine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Scopolamine by Type
8.3 Asia Pacific Scopolamine by Application
8.4 Asia Pacific Scopolamine by Company
9 Central & South America
9.1 Central & South America Scopolamine by Countries
9.1.1 Central & South America Scopolamine Sales by Countries
9.1.2 Central & South America Scopolamine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Scopolamine by Type
9.3 Central & South America Scopolamine by Application
9.4 Central & South America Scopolamine by Company
10 Middle East and Africa
10.1 Middle East and Africa Scopolamine by Countries
10.1.1 Middle East and Africa Scopolamine Sales by Countries
10.1.2 Middle East and Africa Scopolamine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Scopolamine by Type
10.3 Middle East and Africa Scopolamine by Application
10.4 Middle East and Africa Scopolamine by Company
11 Company Profiles
11.1 Alkaloids of Australia
11.1.1 Alkaloids of Australia Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Scopolamine
11.1.4 Scopolamine Product Description
11.1.5 Recent Development
11.2 Centroflora-cms
11.2.1 Centroflora-cms Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Scopolamine
11.2.4 Scopolamine Product Description
11.2.5 Recent Development
11.3 Fine Chemicals Corporation
11.3.1 Fine Chemicals Corporation Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Scopolamine
11.3.4 Scopolamine Product Description
11.3.5 Recent Development
11.4 Phytex Australia
11.4.1 Phytex Australia Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Scopolamine
11.4.4 Scopolamine Product Description
11.4.5 Recent Development
11.5 Alchem International
11.5.1 Alchem International Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Scopolamine
11.5.4 Scopolamine Product Description
11.5.5 Recent Development
11.6 Guangzhou Hanfang
11.6.1 Guangzhou Hanfang Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Scopolamine
11.6.4 Scopolamine Product Description
11.6.5 Recent Development
11.7 Alkaloids Corporation
11.7.1 Alkaloids Corporation Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Scopolamine
11.7.4 Scopolamine Product Description
11.7.5 Recent Development
11.8 Luyin
11.8.1 Luyin Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Scopolamine
11.8.4 Scopolamine Product Description
11.8.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Scopolamine Raw Material
13.1.2 Scopolamine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
This research report categorizes the global Scopolamine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
Request a Free PDF Sample Report @ http://decisionmarketreports.com/request-sample?productID=858430
Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
The global production of scopolamine about 2450 Kg in 2015, the production region is mainly concentrated in Australia witch product 43.63% of global scopolamine. The top three companies are Alkaloids of Australia, Centroflora-cms and Fine Chemicals Corporation, they occupies about 62.37% market shares.
Although the production region is very concentration, the consumption region is very dispersion, in 2015, the largest consumption North America is about 30.68%, the Europe consumes about 26.65% market share, China occupies about 9.88% market share, Japan occupies about 10.78% market share.
In 2017, the global Scopolamine market size was 16 million US$ and is forecast to 20 million US in 2025, growing at a CAGR of 3.0% from 2018. The objectives of this study are to define, segment, and project the size of the Scopolamine market based on company, product type, application and key regions.
Browse Complete Report with Table of Content @ http://decisionmarketreports.com/market-reports/858430/global-scopolamine-market
The various contributors involved in the value chain of Scopolamine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Scopolamine include
Alkaloids of Australia
Centroflora-cms
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
Market Size Split by Type
Scopolamine Butylbromide
Scopolamine Hydrobromide
Scopolamine Base
Market Size Split by Application
Oral
Injection
Patches
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Scopolamine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Scopolamine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Scopolamine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Scopolamine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Scopolamine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Scopolamine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Scopolamine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Scopolamine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Scopolamine Market Size Growth Rate by Type
1.4.2 Scopolamine Butylbromide
1.4.3 Scopolamine Hydrobromide
1.4.4 Scopolamine Base
1.5 Market by Application
1.5.1 Global Scopolamine Market Size Growth Rate by Application
1.5.2 Oral
1.5.3 Injection
1.5.4 Patches
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Scopolamine Market Size
2.1.1 Global Scopolamine Revenue 2016-2025
2.1.2 Global Scopolamine Sales 2016-2025
2.2 Scopolamine Growth Rate by Regions
2.2.1 Global Scopolamine Sales by Regions
2.2.2 Global Scopolamine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Scopolamine Sales by Manufacturers
3.1.1 Scopolamine Sales by Manufacturers
3.1.2 Scopolamine Sales Market Share by Manufacturers
3.1.3 Global Scopolamine Market Concentration Ratio (CR5 and HHI)
3.2 Scopolamine Revenue by Manufacturers
3.2.1 Scopolamine Revenue by Manufacturers (2016-2018)
3.2.2 Scopolamine Revenue Share by Manufacturers (2016-2018)
3.3 Scopolamine Price by Manufacturers
3.4 Scopolamine Manufacturing Base Distribution, Product Types
3.4.1 Scopolamine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Scopolamine Product Category
3.4.3 Date of International Manufacturers Enter into Scopolamine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Scopolamine Sales by Type
4.2 Global Scopolamine Revenue by Type
4.3 Scopolamine Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Scopolamine Breakdown Data by Application
6 North America
6.1 North America Scopolamine by Countries
6.1.1 North America Scopolamine Sales by Countries
6.1.2 North America Scopolamine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Scopolamine by Type
6.3 North America Scopolamine by Application
6.4 North America Scopolamine by Company
7 Europe
7.1 Europe Scopolamine by Countries
7.1.1 Europe Scopolamine Sales by Countries
7.1.2 Europe Scopolamine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Scopolamine by Type
7.3 Europe Scopolamine by Application
7.4 Europe Scopolamine by Company
8 Asia Pacific
8.1 Asia Pacific Scopolamine by Countries
8.1.1 Asia Pacific Scopolamine Sales by Countries
8.1.2 Asia Pacific Scopolamine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Scopolamine by Type
8.3 Asia Pacific Scopolamine by Application
8.4 Asia Pacific Scopolamine by Company
9 Central & South America
9.1 Central & South America Scopolamine by Countries
9.1.1 Central & South America Scopolamine Sales by Countries
9.1.2 Central & South America Scopolamine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Scopolamine by Type
9.3 Central & South America Scopolamine by Application
9.4 Central & South America Scopolamine by Company
10 Middle East and Africa
10.1 Middle East and Africa Scopolamine by Countries
10.1.1 Middle East and Africa Scopolamine Sales by Countries
10.1.2 Middle East and Africa Scopolamine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Scopolamine by Type
10.3 Middle East and Africa Scopolamine by Application
10.4 Middle East and Africa Scopolamine by Company
11 Company Profiles
11.1 Alkaloids of Australia
11.1.1 Alkaloids of Australia Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Scopolamine
11.1.4 Scopolamine Product Description
11.1.5 Recent Development
11.2 Centroflora-cms
11.2.1 Centroflora-cms Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Scopolamine
11.2.4 Scopolamine Product Description
11.2.5 Recent Development
11.3 Fine Chemicals Corporation
11.3.1 Fine Chemicals Corporation Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Scopolamine
11.3.4 Scopolamine Product Description
11.3.5 Recent Development
11.4 Phytex Australia
11.4.1 Phytex Australia Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Scopolamine
11.4.4 Scopolamine Product Description
11.4.5 Recent Development
11.5 Alchem International
11.5.1 Alchem International Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Scopolamine
11.5.4 Scopolamine Product Description
11.5.5 Recent Development
11.6 Guangzhou Hanfang
11.6.1 Guangzhou Hanfang Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Scopolamine
11.6.4 Scopolamine Product Description
11.6.5 Recent Development
11.7 Alkaloids Corporation
11.7.1 Alkaloids Corporation Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Scopolamine
11.7.4 Scopolamine Product Description
11.7.5 Recent Development
11.8 Luyin
11.8.1 Luyin Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Scopolamine
11.8.4 Scopolamine Product Description
11.8.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Scopolamine Raw Material
13.1.2 Scopolamine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Contact Information:
Decision Market Reports
Gasper James
Tel: +1-866-605-1052
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Decision Market Reports
Gasper James
Tel: +1-866-605-1052
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results